ASX Share rice
Sat 15 Aug 2020 - 08:15:pm (Sydney)

PAB Share Price

PATRYS LIMITEDPABPharmaceuticals, Biotechnology & Life Sciences

PAB Company Information

Name:

Patrys Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

100 Albert Road South Melbourne Australia 3205

Phone:

61 3 9692 7222

MD, CEO & Director:

Dr. James A. Campbell B.Sc., Ph.D., MBA

Company Sec.:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

VP of Bus. Devel. & Intellectual Property:

Dr. Deanne Greenwood GAICD, Ph.D., MBA

Company Overview:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

PAB Share Price Information

Shares Issued:

1.43B

Market Capitalisation:

$17.16M

Revenue (TTM):

$746.24K

Revenue Per Share (TTM):

$0

Operating Margin (TTM):

$-4.04

Return On Assets (TTM):

$-0.25

Return On Equity (TTM):

$-0.42

Quarterly Revenue Growth (YOY):

-0.449

Gross Profit(TTM):

$844.37K

Diluted Earnings Per Share (TTM):

$-0.003

PAB CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$2M

Change To Liabilities:

$-95,298

Total Cashflow From Investing Activities:

$2M

Net Income:

$-411,326

Total Cash From Operating Activities:

$-129,185

Depreciation:

$48.31K

Change To Account Receivables:

$-96,823

Capital Expenditures:

$4.06K

PAB Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-411,326

Net Income:

$-411,326

Gross Profit:

$27.50K

Operating Income:

$-4,228,191

Total Revenue:

$27.50K

Total Operating Expenses:

$4.26M

PAB Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$573.75K

Total Liabilities:

$637.42K

Total Stockholder Equity:

$7.30M

Other Current Liabilities:

$280.27K

Total Assets:

$7.93M

Common Stock:

$67.07M

Retained Earnings:

$-60,724,279

Other Liabilities:

$16.35K

Cash:

$6.47M

Total Current Liabilities:

$621.08K

Property - Plant & Equipment:

$6.38K

Net Tangible Assets:

$6.72M

Total Current Assets:

$7.35M

Net Receivables:

$740.55K

Short-Term Investments:

$580.13K

Accounts Payable:

$198.99K

Non Currrent Assets (Other):

$580.13K

Short-Term Investments:

$580.13

Non Current Liabilities Total:

$16.35K

PAB Share Price History

PAB News

18 May, 2020
It hasn't been the best quarter for Patrys Limited (ASX:PAB) shareholders, since the share price has fallen 28% in...
18 Mar, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
18 Jan, 2020
James Campbell has been the CEO of Patrys Limited (ASX:PAB) since 2015. This analysis aims first to contrast CEO...
04 Oct, 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...